GSK and CureVac Restructure Partnership, Focusing on MRNA Vaccine Development
GSK plc (NYSE:GSK) and CureVac N.V. (NASDAQ:CVAC) today announced they have restructured their existing collaboration into a new licensing agreement, allowing each company to prioritize investment and
Avid Bioservices Reports Mixed Q4 Results; Initiates FY24 Outlook
Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory, increasing by 0.6% to finish at 5,509.01. Additionally, th
Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
On Tuesday, Cathie Wood-led Ark Invest made significant adjustments to its portfolio, offloading a substantial number of shares in Tesla Inc (NASDAQ:TSLA) and scooping up a hefty stake in Palantir Tec
Earnings Call Summary | Avid Bioservices(CDMO.US) Q4 2024 Earnings Conference
The following is a summary of the Avid Bioservices, Inc. (CDMO) Q4 2024 Earnings Call Transcript:Financial Performance:Avid Bioservices reported Q4 FY2024 revenue of $43 million, an 8% increase year-o
Looking Into Regeneron Pharmaceuticals's Recent Short Interest
Regeneron Pharmaceuticals's (NYSE:REGN) short percent of float has risen 5.99% since its last report. The company recently reported that it has 1.85 million shares sold short, which is 1.77% of all re